Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel

BACKGROUND: Chemotherapy with praziquantel (PZQ) is the mainstay of schistosomiasis control. However, there are recent concerns about tolerance or resistance to PZQ, so that monitoring its efficacy in different settings is required. METHODS: A longitudinal study was conducted to evaluate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Abedaziz M, Abbas, Hana, Mansour, Fathi A, Gasim, Gasim I, Adam, Ishag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434009/
https://www.ncbi.nlm.nih.gov/pubmed/22676052
http://dx.doi.org/10.1186/1756-3305-5-108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434009/
https://www.ncbi.nlm.nih.gov/pubmed/22676052
http://dx.doi.org/10.1186/1756-3305-5-108

Ejemplares similares